Michael P Curry
Affiliation: Harvard University
- Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label studyMichael P Curry
Transplant Institute, Beth Israel Deaconess Medical Center, Boston, Massachusetts Electronic address
Gastroenterology 148:100-107.e1. 2015..We performed a trial to determine whether sofosbuvir and ribavirin treatment before liver transplantation could prevent HCV recurrence afterward...
- HIV and hepatitis C virus: special concerns for patients with cirrhosisMichael P Curry
Liver Center, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA
J Infect Dis 207:S40-4. 2013....
- Use of growth factors with antiviral therapy for chronic hepatitis CMichael P Curry
Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA
Clin Liver Dis 9:439-51, vii. 2005....
- Hepatitis B and hepatitis C viruses in liver transplantationMichael P Curry
Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
Transplantation 78:955-63. 2004..This review summarizes available data and highlights appropriate strategies to improve outcomes...
- The gallbladder and biliary tract in cystic fibrosisMichael P Curry
Liver Transplantation, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
Curr Gastroenterol Rep 7:147-53. 2005..Liver transplantation can be performed successfully in patients with end-stage liver disease. Future treatments involve targeted gene therapy and activation of mutant forms of the cystic fibrosis transmembrane conductance regulator...
- Timing of sirolimus conversion influences recovery of renal function in liver transplant recipientsChristin C Rogers
Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, MA, USA
Clin Transplant 23:887-96. 2009..The only improvement in the LC group was from conversion to the three-month time point. We conclude that EC to SRL results in a profound improvement in eGFR that begins at three months and is sustained beyond one yr...
- A simultaneous liver-kidney transplant recipient with IgA nephropathy limited to native kidneys and BK virus nephropathy limited to the transplant kidneyManasa P Ujire
The Transplant Institute, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
Am J Kidney Dis 62:331-4. 2013..These findings confirm the predilection of BK virus nephropathy for transplant rather than native kidneys. ..
- Liver transplant center risk toleranceScott R Johnson
The Transplant Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
Clin Transplant 26:E269-76. 2012..Small volume centers must perform higher risk transplants to meet current CMS requirements and are at risk for adverse action secondary to chance alone...
- The optimal timing of hepatitis C therapy in transplant eligible patients with Child B and C Cirrhosis: A Cost-Effectiveness AnalysisElliot B Tapper
1Division of Gastroenterology Hepatology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA2Harvard Medical School3Liver Unit, Department of Internal Medicine, Hospital Valle Hebron and Ciberehd del Institut Carlos III, Barcelona, Spain4Hepatology, University Clinic for Visceral Surgery and Medicine, Inselspital, University of Berne, Switzerland5Division of Gastroenterology Hepatology, Northwestern University, Chicago, IL
Transplantation . 2016..Ledipasvir/sofosbuvir (LDV/SOF) has demonstrated high efficacy, safety and tolerability in HCV-infected patients. There is limited data, however, regarding the optimal timing of therapy in the context of possible liver transplantation (LT)...
- Peripheral platelet count correlates with liver atrophy and predicts long-term mortality on the liver transplant waiting listWissam Bleibel
Liver Center, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA, USA
Transpl Int 26:435-42. 2013..01), but no different transplantation rate (36.7% vs. 33.3%, P = 0.64) compared to those with platelet count ≥ 100,000/mcL. Low platelet count corresponds to higher waiting list mortality and is a sign of advanced liver atrophy...
- Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus InfectionMing V Lin
Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, United States of America
PLoS ONE 11:e0158431. 2016..In this multi-center series of patients, all-oral DAA therapy appears to be safe and effective in post-kidney transplant patients with chronic HCV infection. ..
- Evaluation of proton pump inhibitor use on treatment outcomes with ledipasvir and sofosbuvir in a real-world cohort studyElliot B Tapper
Division of Gastroenterology Hepatology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
Hepatology 64:1893-1899. 2016..However, in a sensitivity analysis focusing on patients with cirrhosis, twice-daily PPI use was associated with lower odds ratio for SVR12 (0.11; 95% CI, 0.02-0.59)...
- Serum Ammonia in Associated With Transplant-free Survival in Hospitalized Patients With Acutely Decompensated CirrhosisVilas R Patwardhan
Division of Gastroenterology Department of Medicine Decision Support, Beth Israel Deaconess Medical Center, Boston, MA
J Clin Gastroenterol 50:345-50. 2016....
- Patients' expectations and success criteria for liver transplantationJames R Rodrigue
Center for Transplant Outcomes and Quality Improvement, Transplant Institute, Beth Israel Deaconess Medical Center, Boston, MA, USA
Liver Transpl 17:1309-17. 2011..Patient-centered assessments have the potential to facilitate provider-patient communication by helping patients to prioritize their goals for LT and make informed choices on the basis of those priorities...
- Donor postextubation hypotension and age correlate with outcome after donation after cardiac death transplantationKaren J Ho
Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
Transplantation 85:1588-94. 2008..We hypothesized that donor postextubation parameters, including duration and severity of hemodynamic instability or hypoxia might be a better predictor of subsequent graft function...
- Atypical radiological presentation of progressive multifocal leukoencephalopathy following liver transplantationMarco A Lima
Department of Neurology, Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
J Neurovirol 11:46-50. 2005..The authors report an atypical presentation of PML with contrast-enhancing lesions and mass effect on the MRI in a liver transplant recipient,who had a progressive course and fatal outcome...
- Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liverMichael P Curry
The Liver Unit, St Vincent s University Hospital, Elm Park, Dublin 4, Ireland
J Hepatol 38:642-50. 2003....
- Decrease in hepatic CD56(+) T cells and V alpha 24(+) natural killer T cells in chronic hepatitis C viral infectionTina Deignan
Education and Research Centre, St Vincent s University Hospital, Elm Park, Dublin 4, Ireland
J Hepatol 37:101-8. 2002..It is not known which of these populations contribute to immunity against HCV or immune pathology...